NovoLog is a mealtime (rapid-acting) insulin. It’s a brand-name form of insulin aspart. For type 1 diabetes, you’ll typically inject NovoLog before your meals throughout the day. For type 2 diabetes, ...
On Feb. 14, the agency approved the drug, a biosimilar to Novolog, for glycemic control improvement in adult and pediatric diabetic patients. The subcutaneous medication is approved in a 3 milliliter, ...
Humalog is given as an injection, and there are two types of the drug: Some forms of Humalog and Humalog Mix are available as generics or biosimilars. To learn more, see “Generic or biosimilar ...
The expanded approval was based on data from the phase 3 PRONTO-PUMP-2 trial which evaluated Lyumjev vs Humalog for use in insulin pump therapy in 432 adults with type 1 diabetes. The Food and Drug ...
Larissa Banitt is a registered nurse who combines her English and Nursing degrees in writing health content. She has worked on the floor on a medical-surgical unit and currently works providing care ...
Basaglar (insulin glargine) is a brand-name drug that’s used to help manage blood sugar levels in certain people. The drug comes as a liquid solution that’s injected under your skin. It’s usually ...
A revolutionary technology could dramatically improve the well-being of diabetic patients through a simple and straightforward way: an insulin oral delivery system that could replace traditional ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Subcutaneous insulin therapy was associated with shorter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results